L66P (p.Leu66Pro) variant of UMOD (Uromodulin)

L66P (p.Leu66Pro) in UMOD (Uromodulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Familial juvenile hyperuricemic nephropathy type 1; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.70 / 1. The record also includes published literature and structural context.

L66P (p.Leu66Pro) variant details